Maria Agnese Fabbri

6PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 24, 2025
Adherence to Aromatase Inhibitor Therapy in Breast Cancer: Insights From a Multicenter Italian Study.

Maria Agnese Fabbri, Alberto Fulvi, Matteo Vergati

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|Jun 26, 2025
Periodic Boosters of COVID-19 Vaccines Do Not Affect the Safety and Efficacy of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: A Longitudinal Analysis of the Vax-On-Third Study.

Agnese Fabbri, Enzo Maria Ruggeri, Antonella Virtuoso

|Mar 10, 2025
Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data.

Fabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso

|Dec 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri

|May 26, 2023
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.

Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso

Pageof 1

Frequent Collaborators

3 joint publications

Carlo Signorelli

2 joint publications

Fabrizio Nelli

2 joint publications

Diana Giannarelli

2 joint publications

Gloria Pessina